plinabulin (BPI 2358)

News alerts, weekly reports and conference planners

Company:

BeyondSpring, Jiangsu Hengrui Pharma

Drug class:

GEF-H1 activator

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

EGFR wild-type	Lung Non-Squamous Non-Small Cell Cancer	EGFR wild-type	Lung Non-Squamous Non-Small Cell Cancer	docetaxel + BPI 2358 Sensitive: B - Late Trials docetaxel + BPI 2358 Sensitive : B	docetaxel + BPI 2358 Sensitive: B - Late Trials docetaxel + BPI 2358 Sensitive : B
EGFR wild-type	Non Small Cell Lung Cancer	EGFR wild-type	Non Small Cell Lung Cancer	docetaxel + BPI 2358 Sensitive: B - Late Trials docetaxel + BPI 2358 Sensitive : B	docetaxel + BPI 2358 Sensitive: B - Late Trials docetaxel + BPI 2358 Sensitive : B

Associations
(2)